Losartan-HCTZ 100-12.5 mg combination will be more effective in lower mean through sitting diastolic blood pressure (SiDBP) than losartan 100 mg monotherapy after 6 weeks of treatment.
Losartan-HCTZ 100-12.5 mg combination will be more effective in lowering mean through sitting systolic blood pressure (SiSBP) after 6 weeks of treatment compared to losartan 100-mg monotherapy, and will be safe and tolerable.
18 Years and older (Adult, Senior)
December 1, 2004
June 1, 2005
June 2, 2005
March 27, 2006
April 12, 2017
† Study has passed its completion date and status has not been verified in more than two years.